Follow
Prof Bryan W Day (PhD)
Prof Bryan W Day (PhD)
Group Leader, Sid Faithfull Brain Cancer Laboratory, QIMR Berghofer MRI
Verified email at qimrberghofer.edu.au - Homepage
Title
Cited by
Cited by
Year
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
WA Flavahan, Q Wu, M Hitomi, N Rahim, Y Kim, AE Sloan, RJ Weil, ...
Nature neuroscience 16 (10), 1373-1382, 2013
4882013
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme
BW Day, BW Stringer, F Al-Ejeh, MJ Ting, J Wilson, KS Ensbey, ...
Cancer cell 23 (2), 238-248, 2013
2542013
Circulating biomarkers in patients with glioblastoma
J Müller Bark, A Kulasinghe, B Chua, BW Day, C Punyadeera
British journal of cancer 122 (3), 295-305, 2020
1882020
A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis
HJ Abuhusain, A Matin, Q Qiao, H Shen, N Kain, BW Day, BW Stringer, ...
Journal of Biological Chemistry 288 (52), 37355-37364, 2013
1532013
A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
BW Stringer, BW Day, RCJ D’Souza, PR Jamieson, KS Ensbey, ZC Bruce, ...
Scientific reports 9 (1), 4902, 2019
1512019
Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors
PW Janes, B Griesshaber, L Atapattu, E Nievergall, LL Hii, A Mensinga, ...
Journal of Cell Biology 195 (6), 1033-1045, 2011
1172011
On the origin of bound exciton lines in indium phosphide and gallium arsenide
AM White, PJ Dean, B Day
Journal of Physics C: Solid State Physics 7 (7), 1400, 1974
1141974
A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cells
YC Lim, TL Roberts, BW Day, A Harding, S Kozlov, AW Kijas, KS Ensbey, ...
Molecular cancer therapeutics 11 (9), 1863-1872, 2012
1092012
Extracellular vesicles released by glioblastoma cells stimulate normal astrocytes to acquire a tumor-supportive phenotype via p53 and MYC signaling pathways
S Hallal, DM Mallawaaratchy, H Wei, S Ebrahimkhani, BW Stringer, ...
Molecular neurobiology 56, 4566-4581, 2019
1022019
Differential response of patient-derived primary glioblastoma cells to environmental stiffness
TJ Grundy, E De Leon, KR Griffin, BW Stringer, BW Day, B Fabry, ...
Scientific reports 6 (1), 23353, 2016
1022016
The photoluminescence spectra of excitons bound to group II acceptors in indium phosphide
AM White, PJ Dean, KM Fairhurst, W Bardsley, EW Williams, B Day
Solid State Communications 11 (9), 1099-1103, 1972
971972
Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis
Y Li, Q Song, BW Day
Acta neuropathologica communications 7, 1-8, 2019
952019
Eph receptors as therapeutic targets in glioblastoma
BW Day, BW Stringer, AW Boyd
British journal of cancer 111 (7), 1255-1261, 2014
922014
Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage
JA Betts, MM Marjaneh, F Al-Ejeh, YC Lim, W Shi, H Sivakumaran, ...
The American Journal of Human Genetics 101 (2), 255-266, 2017
902017
Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells
YC Lim, TL Roberts, BW Day, BW Stringer, S Kozlov, S Fazry, ZC Bruce, ...
Molecular oncology 8 (8), 1603-1615, 2014
862014
NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development
M Piper, G Barry, TJ Harvey, R McLeay, AG Smith, L Harris, S Mason, ...
Journal of Neuroscience 34 (8), 2921-2930, 2014
812014
Combination of palbociclib and radiotherapy for glioblastoma
S Whittaker, D Madani, S Joshi, SA Chung, T Johns, B Day, M Khasraw, ...
Cell death discovery 3 (1), 1-6, 2017
762017
Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines
M Rahman, K Reyner, L Deleyrolle, S Millette, H Azari, BW Day, ...
Anatomy & cell biology 48 (1), 25, 2015
732015
Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma
SA Greenall, YC Lim, CB Mitchell, KS Ensbey, BW Stringer, AL Wilding, ...
Oncogenesis 6 (5), e336-e336, 2017
702017
Glioma surgical aspirate: a viable source of tumor tissue for experimental research
BW Day, BW Stringer, J Wilson, RL Jeffree, PR Jamieson, KS Ensbey, ...
Cancers 5 (2), 357-371, 2013
602013
The system can't perform the operation now. Try again later.
Articles 1–20